Pancreatic Cancer Research

ResearcherUniversity of Nebraska Medical CenterNo recent work listed

Richard G. MacDonald

Verified by OpenAlex author ID and NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5052434334; NIH RePORTER profile ID 1955800. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
1
Labs led
1
Collaborators
13
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: 1 grant

Papers 2

  1. Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis. Co-author DOI 10.18632/oncotarget.2990↗
  2. Relevance of amyloid precursor-like protein 2 C-terminal fragments in pancreatic cancer cells. Co-author DOI 10.3892/ijo.2012.1553↗

Grants 1

  1. IGF-II-Based Approach to Therapy for Pancreatic Cancer R21CA198292↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haley L. Peters · 2 shared papers, 2012–2015 · strength 0.07
  2. Michael Anthony Hollingsworth · 2 shared papers, 2012–2015 · strength 0.07
  3. Joyce C. Solheim · 2 shared papers, 2012–2015 · strength 0.07
  4. Jane L. Meza · 1 shared paper, 2015 · strength 0.04
  5. Poomy Pandey · 1 shared paper, 2015 · strength 0.04
  6. Srustidhar Das · 1 shared paper, 2015 · strength 0.04
  7. Parthasarathy Seshacharyulu · 1 shared paper, 2015 · strength 0.04
  8. Dhanya Haridas · 1 shared paper, 2015 · strength 0.04
  9. Surinder K. Batra · 1 shared paper, 2015 · strength 0.04
  10. Sukhwinder Kaur · 1 shared paper, 2015 · strength 0.04
  11. Prakash Radhakrishnan · 1 shared paper, 2015 · strength 0.04
  12. Satyanarayana Rachagani · 1 shared paper, 2015 · strength 0.04
  13. Michel M. Ouellette · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.